256 related articles for article (PubMed ID: 16633158)
1. Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series.
Bona JR
J Clin Psychopharmacol; 2006 Apr; 26(2):215-6. PubMed ID: 16633158
[No Abstract] [Full Text] [Related]
2. Levetiracetam in tardive dyskinesia.
Meco G; Fabrizio E; Epifanio A; Morgante F; Valente M; Vanacore N; Di Rosa AE; Morgante L
Clin Neuropharmacol; 2006; 29(5):265-8. PubMed ID: 16960471
[TBL] [Abstract][Full Text] [Related]
3. Rapid improvement of neuroleptic-induced tardive dyskinesia with levetiracetam in an interictal psychotic patient.
Chen PH; Liu HC
J Clin Psychopharmacol; 2010 Apr; 30(2):205-7. PubMed ID: 20520300
[No Abstract] [Full Text] [Related]
4. Treatment of tardive dyskinesia with levetiracetam in a transplant patient.
Zivković SA; Costa G; Bond G; Abu-Elmagd KM
Acta Neurol Scand; 2008 May; 117(5):351-3. PubMed ID: 17995990
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam in L-dopa-induced dyskinesia.
Meco G; Fabrizio E; Epifanio A; Di Raimondo G; Vanacore N; Morgante L
Clin Neuropharmacol; 2005; 28(2):102-3. PubMed ID: 15795556
[No Abstract] [Full Text] [Related]
6. [Dimethylaminoethanol in the treatment of neuroleptic-induced tardive dyskinesia].
Lambert PA; Wolff P; de Maximy B; Ghenim A
Ann Med Psychol (Paris); 1978 Apr; 136(4):625-9. PubMed ID: 31832
[No Abstract] [Full Text] [Related]
7. Levetiracetam as a treatment for tardive dyskinesia: a case report.
McGavin CL; John V; Musser WS
Neurology; 2003 Aug; 61(3):419. PubMed ID: 12913217
[No Abstract] [Full Text] [Related]
8. Levetiracetam in tardive dyskinesia: an open label study.
Konitsiotis S; Pappa S; Mantas C; Mavreas V
Mov Disord; 2006 Aug; 21(8):1219-21. PubMed ID: 16637037
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic-induced tardive dyskinesia.
Jenner P; Marsden CD
Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
[TBL] [Abstract][Full Text] [Related]
10. The effect of levetiracetam on levodopa induced dyskinesia in patients with Parkinson's disease.
Tousi B; Subramanian T
Parkinsonism Relat Disord; 2005 Aug; 11(5):333-4. PubMed ID: 15949966
[No Abstract] [Full Text] [Related]
11. Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias.
Contin M; Martinelli P; Albani F; Scaglione C; Avoni P; Rizzo G; Baruzzi A
Clin Neuropharmacol; 2007; 30(2):122-4. PubMed ID: 17414945
[No Abstract] [Full Text] [Related]
12. Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine.
Bouckaert F; Herman G; Peuskens J
Int J Geriatr Psychiatry; 2005 Mar; 20(3):287-8. PubMed ID: 15770692
[No Abstract] [Full Text] [Related]
13. Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment.
Schwartz M; Weller B; Erdreich M; Sharf B
J Clin Psychiatry; 1995 May; 56(5):212. PubMed ID: 7737962
[No Abstract] [Full Text] [Related]
14. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.
Casey DE; Povlsen UJ; Meidahl B; Gerlach J
Psychopharmacol Bull; 1986; 22(1):250-3. PubMed ID: 2873612
[No Abstract] [Full Text] [Related]
16. [Quetiapine treatment of risperidone-related tardive dyskinesia. A case report].
Alcantara Lapaz AG; García Fernández L; Martínez MJ
Actas Esp Psiquiatr; 2003; 31(5):306. PubMed ID: 14557956
[No Abstract] [Full Text] [Related]
17. Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesia.
Lyons KE; Pahwa R
Clin Neuropharmacol; 2006; 29(3):148-53. PubMed ID: 16772814
[TBL] [Abstract][Full Text] [Related]
18. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
Kocher R; Hobi V; Linder M; Studer K
Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
[TBL] [Abstract][Full Text] [Related]
19. [Tardive dyskinesia: problems of pathogenesis, treatment and prevention].
Olajossy M
Psychiatr Pol; 1980; 14(6):621-5. PubMed ID: 6112766
[No Abstract] [Full Text] [Related]
20. Treatment of tardive dyskinesia with propranolol.
Schrodt GR; Wright JH; Simpson R; Moore DP; Chase S
J Clin Psychiatry; 1982 Aug; 43(8):328-31. PubMed ID: 6124534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
